| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |